marnetegragene autotemcel (kresladi)
marnetegragene autotemcel is an FDA-licensed reference biologic from Rocket Pharmaceuticals Inc. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2026
Reference approved
Reference product
kresladi marnetegragene autotemcel
Rocket Pharmaceuticals Inc
- Approved
- Mar 26, 2026
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for marnetegragene autotemcel, in chronological order.
Reference approval
Approval date of the reference marnetegragene autotemcel product.
2 mo ago
Frequently asked questions
Are there biosimilars approved for marnetegragene autotemcel (kresladi)?
No 351(k) biosimilars or interchangeable biosimilars referencing marnetegragene autotemcel are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.